April 2024
1. KAVIRAJAN H
   Neglect of Adverse Effects in Treatment Guidelines for Depression.
   Am J Psychiatry. 2024;181:342-345.
   

   >> Share

   
   March 2024
2. STEFFENS DC
   Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul.
   Am J Psychiatry. 2024;181:183-185.
   

   >> Share

   
   
3. PHILLIPS ML
   Multimodal Predictors of Treatment Response in Major Depressive Disorder: Advancing Personalized Medicine in Psychiatry.
   Am J Psychiatry. 2024;181:180-182.
   

   >> Share

   
   
4. POIROT MG, Ruhe HG, Mutsaerts HMM, Maximov II, et al
   Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.
   Am J Psychiatry. 2024;181:223-233.
   

   >> Share

   
   February 2024
5. AINSWORTH NJ, Marawi T, Maslej MM, Blumberger DM, et al
   Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis.
   Am J Psychiatry. 2024 Feb 7:appiajp20230392. doi: 10.1176/appi.ajp.20230392.
   

   >> Share

   
   January 2024
6. KALIN NH
   Improving Clinical Outcomes and Informing New Interventions.
   Am J Psychiatry. 2024;181:1-3.
   

   >> Share

   
   
7. WALASZEK A
   Optimizing the Treatment of Late-Life Depression.
   Am J Psychiatry. 2024;181:7-10.
   

   >> Share

   
   
8. RUBINOW DR
   Suicide and the Menstrual Cycle.
   Am J Psychiatry. 2024;181:11-13.
   

   >> Share

   
   
9. BATAIL JV, Feyder MT, Bentzley BS, Williams NR, et al
   An Avenue for Optimization of Theta Burst Stimulation Protocols? Comments on the FOUR-D Randomized Noninferiority Clinical Trial.
   Am J Psychiatry. 2024;181:68-70.
   

   >> Share

   
   December 2023
10. KALIN NH
    Adversity and Resilience, Postpartum Depression, Suicide, and Racial/Ethnic Disparities.
    Am J Psychiatry. 2023;180:859-861.
    

    >> Share

    
    
11. ADAMS JAM, Chandra P, Mehta D
    The First Large GWAS Meta-Analysis for Postpartum Depression.
    Am J Psychiatry. 2023;180:862-864.
    

    >> Share

    
    
12. STOWE ZN
    Perinatal Mental Health: Advances and Opportunities.
    Am J Psychiatry. 2023;180:874-877.
    

    >> Share

    
    October 2023
13. GUINTIVANO J, Byrne EM, Kiewa J, Yao S, et al
    Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression.
    Am J Psychiatry. 2023 Oct 18:appiajp20230053. doi: 10.1176/appi.ajp.20230053.
    

    >> Share

    
    
14. ISHTIAK-AHMED K, Musliner KL, Christensen KS, Mortensen EL, et al
    Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark.
    Am J Psychiatry. 2023 Oct 18:appiajp20230356. doi: 10.1176/appi.ajp.20230356.
    

    >> Share

    
    
15. SHACKMAN AJ, Gee DG
    Maternal Perinatal Stress Associated With Offspring Negative Emotionality, But the Underlying Mechanisms Remain Elusive.
    Am J Psychiatry. 2023;180:708-711.
    

    >> Share

    
    
16. KALIN NH
    Stress, Heritability, and Genetic Factors Influencing Depression, PTSD, and Suicidal Behavior.
    Am J Psychiatry. 2023;180:699-702.
    

    >> Share

    
    
17. LYNALL ME, McIntosh AM
    The Heterogeneity of Depression.
    Am J Psychiatry. 2023;180:703-704.
    

    >> Share

    
    
18. NGUYEN TD, Kowalec K, Pasman J, Larsson H, et al
    Genetic Contribution to the Heterogeneity of Major Depressive Disorder: Evidence From a Sibling-Based Design Using Swedish National Registers.
    Am J Psychiatry. 2023;180:714-722.
    

    >> Share

    
    
19. FARHAT LC, Blakey R, Davey Smith G, Fujita A, et al
    Networks of Neurodevelopmental Traits, Socioenvironmental Factors, Emotional Dysregulation in Childhood, and Depressive Symptoms Across Development in Two U.K. Cohorts.
    Am J Psychiatry. 2023;180:755-765.
    

    >> Share

    
    
20. CHATZINAKOS C, Pernia CD, Morrison FG, Iatrou A, et al
    Single-Nucleus Transcriptome Profiling of Dorsolateral Prefrontal Cortex: Mechanistic Roles for Neuronal Gene Expression, Including the 17q21.31 Locus, in PTSD Stress Response.
    Am J Psychiatry. 2023;180:739-754.
    

    >> Share

    
    
21. DOCHERTY AR, Mullins N, Ashley-Koch AE, Qin X, et al
    GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.
    Am J Psychiatry. 2023;180:723-738.
    

    >> Share

    
    September 2023
22. PINE DS
    Zuranolone Treatment for Depression: Steady Progress in Mechanism-Focused Therapeutics?
    Am J Psychiatry. 2023;180:631-633.
    

    >> Share

    
    
23. KALIN NH
    Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression.
    Am J Psychiatry. 2023;180:625-628.
    

    >> Share

    
    
24. CLAYTON AH, Lasser R, Parikh SV, Iosifescu DV, et al
    Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial.
    Am J Psychiatry. 2023;180:676-684.
    

    >> Share

    
    July 2023
25. DELIGIANNIDIS KM, Meltzer-Brody S, Maximos B, Peeper EQ, et al
    Zuranolone for the Treatment of Postpartum Depression.
    Am J Psychiatry. 2023 Jul 26:appiajp20220785. doi: 10.1176/appi.ajp.20220785.
    

    >> Share

    
    
26. JESTER DJ, Kohn JN, Tibirica L, Thomas ML, et al
    Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults.
    Am J Psychiatry. 2023;180:483-494.
    

    >> Share

    
    April 2023
27. BIERNACKA JM
    Do Polygenic Scores Inform Psychiatric Disease Risk After Considering Family History?
    Am J Psychiatry. 2023;180:256-258.
    

    >> Share

    
    March 2023
28. ELBAU IG, Lynch CJ, Downar J, Vila-Rodriguez F, et al
    Functional Connectivity Mapping for rTMS Target Selection in Depression.
    Am J Psychiatry. 2023;180:230-240.
    

    >> Share

    
    
29. THASE ME
    A New Option for Depressed Patients Who Do Not Respond to Antidepressant Medications.
    Am J Psychiatry. 2023;180:188-189.
    

    >> Share

    
    
30. KALIN NH
    Insights and Advances Into Treatments for Major Depression.
    Am J Psychiatry. 2023;180:173-176.
    

    >> Share

    
    
31. JHA MK, Mathew SJ
    Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
    Am J Psychiatry. 2023;180:190-199.
    

    >> Share

    
    
32. NUNES EV
    Alcohol and the Etiology of Depression.
    Am J Psychiatry. 2023;180:179-181.
    

    >> Share

    
    
33. SACHS GS, Yeung PP, Rekeda L, Khan A, et al
    Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
    Am J Psychiatry. 2023;180:241-251.
    

    >> Share

    
    
34. DUNLOP BW, Cha J, Choi KS, Rajendra JK, et al
    Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy.
    Am J Psychiatry. 2023;180:218-229.
    

    >> Share

    
    
35. HASSERIS S, Albinana C, Vilhjalmsson BJ, Mortensen PB, et al
    Polygenic Risk and Episode Polarity Among Individuals With Bipolar Disorder.
    Am J Psychiatry. 2023;180:200-208.
    

    >> Share

    
    February 2023
36. BELSKY DW, Domingue BW
    Progress and Challenges in GxE Research on Depression.
    Am J Psychiatry. 2023;180:111-113.
    

    >> Share

    
    January 2023
37. VISONTAY R, Mewton L, Slade T, Aris IM, et al
    Moderate Alcohol Consumption and Depression: A Marginal Structural Model Approach Promoting Causal Inference.
    Am J Psychiatry. 2023 Jan 18:appiajp22010043. doi: 10.1176/appi.ajp.22010043.
    

    >> Share

    
    
38. CLEARY JL, Fang Y, Zahodne LB, Bohnert ASB, et al
    Polygenic Risk and Social Support in Predicting Depression Under Stress.
    Am J Psychiatry. 2023 Jan 11:appiajp21111100. doi: 10.1176/appi.ajp.21111100.
    

    >> Share

    
    December 2022
39. BARBER G, Nemeroff CB, Siegel S
    A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.
    Am J Psychiatry. 2022;179:892-896.
    

    >> Share

    
    
40. SCHATZBERG AF
    An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression.
    Am J Psychiatry. 2022;179:890-891.
    

    >> Share

    
    
41. PRICE RB, Spotts C, Panny B, Griffo A, et al
    A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial.
    Am J Psychiatry. 2022;179:959-968.
    

    >> Share

    
    November 2022
42. JESPERSEN A, Yilmaz Z, Vilhjalmsson BJ
    Harnessing the Power of Population Cohorts to Study the Relationship Between Endocrine-Metabolic Disorders and Depression.
    Am J Psychiatry. 2022;179:788-790.
    

    >> Share

    
    
43. URSANO RJ, Stein MB
    From Soldier's Heart to Shared Genetic Risk: PTSD and Cardiovascular Disease.
    Am J Psychiatry. 2022;179:785-787.
    

    >> Share

    
    
44. SELIGOWSKI AV, Misganaw B, Duffy LA, Ressler KJ, et al
    Leveraging Large-Scale Genetics of PTSD and Cardiovascular Disease to Demonstrate Robust Shared Risk and Improve Risk Prediction Accuracy.
    Am J Psychiatry. 2022;179:814-823.
    

    >> Share

    
    
45. SIGSTROM R, Kowalec K, Jonsson L, Clements CC, et al
    Association Between Polygenic Risk Scores and Outcome of ECT.
    Am J Psychiatry. 2022;179:844-852.
    

    >> Share

    
    September 2022
46. LEONE M, Kuja-Halkola R, Leval A, Butwicka A, et al
    Genetic and Environmental Contribution to the Co-Occurrence of Endocrine-Metabolic Disorders and Depression: A Nationwide Swedish Study of Siblings.
    Am J Psychiatry. 2022 Sep 21:appiajp21090954. doi: 10.1176/appi.ajp.21090954.
    

    >> Share

    
    
47. MARKOWITZ JC, Wright JH, Peeters F, Thase ME, et al
    Psychotherapy's Role for Treatment-Resistant Depression: Reply to Bartova et al.
    Am J Psychiatry. 2022;179:688.
    

    >> Share

    
    
48. RICE F
    The Intergenerational Transmission of Anxiety Disorders and Major Depression.
    Am J Psychiatry. 2022;179:596-598.
    

    >> Share

    
    
49. DURGAM S, Chen R, Calabrese JR, Sachs GS, et al
    Treatments for Depression in Bipolar II Disorder.
    Am J Psychiatry. 2022;179:688-690.
    

    >> Share

    
    
50. BARTOVA L, Fugger G, Dold M, Kautzky A, et al
    Psychotherapy's Role for Treatment-Resistant Depression?
    Am J Psychiatry. 2022;179:687.
    

    >> Share

    
    
51. OSTACHER M
    Treatments for Depression in Bipolar II Disorder: Reply to Durgam et al.
    Am J Psychiatry. 2022;179:690.
    

    >> Share

    
    
52. KENDLER KS, Abrahamsson L, Ohlsson H, Sundquist J, et al
    An Extended Swedish Adoption Study of Anxiety Disorder and Its Cross-Generational Familial Relationship With Major Depression.
    Am J Psychiatry. 2022;179:640-649.
    

    >> Share

    
    
53. JAFFE AE, Tao R, Page SC, Maynard KR, et al
    Decoding Shared Versus Divergent Transcriptomic Signatures Across Cortico-Amygdala Circuitry in PTSD and Depressive Disorders.
    Am J Psychiatry. 2022;179:673-686.
    

    >> Share

    
    July 2022
54. HARVEY PD
    Digital Therapeutics to Enhance Cognition in Major Depression: How Can We Make the Cognitive Gains Translate Into Functional Improvements?
    Am J Psychiatry. 2022;179:445-447.
    

    >> Share

    
    
55. FERRARELLI F
    Is Neuroplasticity Key to Treatment Response in Depression? Maybe So.
    Am J Psychiatry. 2022;179:451-453.
    

    >> Share

    
    
56. PIZZAGALLI DA
    Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?
    Am J Psychiatry. 2022;179:458-469.
    

    >> Share

    
    
57. TAMM S, Harmer CJ, Schiel J, Holub F, et al
    No Association Between Amygdala Responses to Negative Faces and Depressive Symptoms: Cross-Sectional Data from 28,638 Individuals in the UK Biobank Cohort.
    Am J Psychiatry. 2022;179:509-513.
    

    >> Share

    
    
58. KALIN NH
    Neuroscientific Advances Supporting New Treatments for Major Depression.
    Am J Psychiatry. 2022;179:441-444.
    

    >> Share

    
    
59. GROGANS SE, Fox AS, Shackman AJ
    The Amygdala and Depression: A Sober Reconsideration.
    Am J Psychiatry. 2022;179:454-457.
    

    >> Share

    
    
60. TABUTEAU H, Jones A, Anderson A, Jacobson M, et al
    Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial.
    Am J Psychiatry. 2022;179:490-499.
    

    >> Share

    
    June 2022
61. HANKERSON SH, Moise N, Wilson D, Waller BY, et al
    The Intergenerational Impact of Structural Racism and Cumulative Trauma on Depression.
    Am J Psychiatry. 2022;179:434-440.
    

    >> Share

    
    May 2022
62. GE R, Humaira A, Gregory E, Alamian G, et al
    Predictive Value of Acute Neuroplastic Response to rTMS in Treatment Outcome in Depression: A Concurrent TMS-fMRI Trial.
    Am J Psychiatry. 2022 May 18:appiajp21050541. doi: 10.1176/appi.ajp.21050541.
    

    >> Share

    
    
63. PAN PM, Sato JR, Paillere Martinot ML, Martinot JL, et al
    Longitudinal Trajectory of the Link Between Ventral Striatum and Depression in Adolescence.
    Am J Psychiatry. 2022 May 18:appiajp20081180. doi: 10.1176/appi.ajp.20081180.
    

    >> Share

    
    April 2022
64. KEEFE RSE, Canadas E, Farlow D, Etkin A, et al
    Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults.
    Am J Psychiatry. 2022 Apr 12:appiajp21020125. doi: 10.1176/appi.ajp.21020125.
    

    >> Share

    
    February 2022
65. MARKOWITZ JC, Wright JH, Peeters F, Thase ME, et al
    The Neglected Role of Psychotherapy for Treatment-Resistant Depression.
    Am J Psychiatry. 2022;179:90-93.
    

    >> Share

    
    
66. WEISSMAN CR, Daskalakis ZJ
    Accelerated Intermittent Theta Burst Stimulation: Expediting and Enhancing Treatment Outcomes in Treatment-Resistant Depression.
    Am J Psychiatry. 2022;179:85-87.
    

    >> Share

    
    
67. NEMEROFF CB
    Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression.
    Am J Psychiatry. 2022;179:83-84.
    

    >> Share

    
    
68. FAVA M, Stahl S, Pani L, De Martin S, et al
    REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.
    Am J Psychiatry. 2022;179:122-131.
    

    >> Share

    
    
69. COLE EJ, Phillips AL, Bentzley BS, Stimpson KH, et al
    Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial.
    Am J Psychiatry. 2022;179:132-141.
    

    >> Share

    
    January 2022
70. KVARTA M, Ma Y, Hong LE
    Comment on "Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank".
    Am J Psychiatry. 2022;179:73.
    

    >> Share

    
    December 2021
71. MCINTYRE RS
    Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg.
    Am J Psychiatry. 2021;178:1130-1132.
    

    >> Share

    
    
72. PARIANTE CM
    Increased Inflammation in Depression: A Little in All, or a Lot in a Few?
    Am J Psychiatry. 2021;178:1077-1079.
    

    >> Share

    
    
73. KALIN NH
    New Insights Into Major Depression and the Treatment of Bipolar Depression.
    Am J Psychiatry. 2021;178:1071-1074.
    

    >> Share

    
    
74. CONROY SK, Holtzheimer PE
    Neuromodulation Strategies for the Treatment of Depression.
    Am J Psychiatry. 2021;178:1082-1088.
    

    >> Share

    
    
75. OSTACHER MJ
    Slowly Working Toward More Treatments for Depression in Bipolar II Disorder.
    Am J Psychiatry. 2021;178:1075-1076.
    

    >> Share

    
    
76. SCHATZBERG AF
    Mechanisms of Action of Ketamine and Esketamine.
    Am J Psychiatry. 2021;178:1130.
    

    >> Share

    
    
77. REUS VI
    Recommendations for the Usage of Ketamine and Esketamine.
    Am J Psychiatry. 2021;178:1129.
    

    >> Share

    
    
78. ZHUKOVSKY P, Anderson JAE, Coughlan G, Mulsant BH, et al
    Coordinate-Based Network Mapping of Brain Structure in Major Depressive Disorder in Younger and Older Adults: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2021;178:1119-1128.
    

    >> Share

    
    
79. CALABRESE JR, Durgam S, Satlin A, Vanover KE, et al
    Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
    Am J Psychiatry. 2021;178:1098-1106.
    

    >> Share

    
    November 2021
80. KEDING TJ, Heyn SA, Russell JD, Zhu X, et al
    Differential Patterns of Delayed Emotion Circuit Maturation in Abused Girls With and Without Internalizing Psychopathology.
    Am J Psychiatry. 2021;178:1026-1036.
    

    >> Share

    
    October 2021
81. FRANK P, Jokela M, Batty GD, Cadar D, et al
    Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies.
    Am J Psychiatry. 2021 Oct 14:appiajp202120121776.
    

    >> Share

    
    
82. KALIN NH
    Depression and Schizophrenia: Sleep, Medical Risk Factors, Biomarkers, and Treatment.
    Am J Psychiatry. 2021;178:881-884.
    

    >> Share

    
    
83. PLANTE DT
    The Evolving Nexus of Sleep and Depression.
    Am J Psychiatry. 2021;178:896-902.
    

    >> Share

    
    
84. MCINTYRE RS
    Surrogate Markers of Insulin Resistance in Predicting Major Depressive Disorder: Metabolism Metastasizes to the Brain.
    Am J Psychiatry. 2021;178:885-887.
    

    >> Share

    
    
85. WATSON KT, Simard JF, Henderson VW, Nutkiewicz L, et al
    Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study.
    Am J Psychiatry. 2021;178:914-920.
    

    >> Share

    
    July 2021
86. ROXAS N, Ahuja C, Isom J, Wilkinson ST, et al
    A Potential Case of Acute Ketamine Withdrawal: Clinical Implications for the Treatment of Refractory Depression.
    Am J Psychiatry. 2021;178:588-591.
    

    >> Share

    
    June 2021
87. PENNINX BWJH
    Using the Power of a Giant Wisely: Confirming Inflammation in Depression.
    Am J Psychiatry. 2021;178:480-482.
    

    >> Share

    
    
88. KALIN NH
    COVID-19 and Stress-Related Disorders.
    Am J Psychiatry. 2021;178:471-474.
    

    >> Share

    
    
89. RUBINOW DR, Lasser R, Kanes SJ
    Comment on "Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids".
    Am J Psychiatry. 2021;178:572-573.
    

    >> Share

    
    May 2021
90. PITHAROULI MC, Hagenaars SP, Glanville KP, Coleman JRI, et al
    Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank.
    Am J Psychiatry. 2021 May 14:appiajp202020060947.
    

    >> Share

    
    
91. MAIXNER DF, Weiner R, Reti IM, Hermida AP, et al
    Electroconvulsive Therapy Is an Essential Procedure.
    Am J Psychiatry. 2021;178:381-382.
    

    >> Share

    
    
92. SCHATZBERG AF
    Can Target Engagement Studies Miss Their Targets and Mislead Drug Development?
    Am J Psychiatry. 2021;178:372-374.
    

    >> Share

    
    
93. FERRARELLI F, Phillips ML
    Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments.
    Am J Psychiatry. 2021;178:400-413.
    

    >> Share

    
    April 2021
94. KALIN NH
    Anxiety, Depression, and Suicide in Youth.
    Am J Psychiatry. 2021;178:275-279.
    

    >> Share

    
    
95. PARIKH T, Walkup JT
    The Future of Ketamine in the Treatment of Teen Depression.
    Am J Psychiatry. 2021;178:288-289.
    

    >> Share

    
    
96. NEMEROFF CB
    The Trifecta of Misery and Disease Vulnerability: Poverty, Childhood Maltreatment, and Inflammation.
    Am J Psychiatry. 2021;178:282-284.
    

    >> Share

    
    
97. BOELEN PA, Lenferink LIM, Spuij M
    CBT for Prolonged Grief in Children and Adolescents: A Randomized Clinical Trial.
    Am J Psychiatry. 2021;178:294-304.
    

    >> Share

    
    
98. SEQUEIRA SL, Silk JS, Ladouceur CD, Hanson JL, et al
    Association of Neural Reward Circuitry Function With Response to Psychotherapy in Youths With Anxiety Disorders.
    Am J Psychiatry. 2021;178:343-351.
    

    >> Share

    
    
99. BIERMAN KL, Heinrichs BS, Welsh JA, Nix RL, et al
    Reducing Adolescent Psychopathology in Socioeconomically Disadvantaged Children With a Preschool Intervention: A Randomized Controlled Trial.
    Am J Psychiatry. 2021;178:305-312.
    

    >> Share

    
    March 2021
100. MCINTYRE RS, Rosenblat JD, Nemeroff CB, Sanacora G, et al
     Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
     Am J Psychiatry. 2021 Mar 17:appiajp202020081251.
     

     >> Share

     
     
101. DWYER JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, et al
     Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
     Am J Psychiatry. 2021 Mar 3:appiajp202020010018.
     

     >> Share

     
     
102. COSTI S, Morris LS, Kirkwood KA, Hoch M, et al
     Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
     Am J Psychiatry. 2021 Mar 3:appiajp202020050653.
     

     >> Share

     
     
103. RUBINOW DR
     One Small Step for PMDD, One Large Step for Affective Disorders.
     Am J Psychiatry. 2021;178:215-217.
     

     >> Share

     
     
104. COMASCO E, Kopp Kallner H, Bixo M, Hirschberg AL, et al
     Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
     Am J Psychiatry. 2021;178:256-265.
     

     >> Share

     
     
105. KLEINMAN RA, Schatzberg AF
     Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids.
     Am J Psychiatry. 2021;178:221-223.
     

     >> Share

     
     February 2021
106. SUMMERS RF, Gorrindo T, Hwang S, Aggarwal R, et al
     Psychiatrist Burnout: Response to Schonfeld and Bianchi.
     Am J Psychiatry. 2021;178:204-205.
     

     >> Share

     
     
107. SCHONFELD IS, Bianchi R
     Psychiatrist Burnout.
     Am J Psychiatry. 2021;178:204.
     

     >> Share

     
     
108. FEDER A, Costi S, Rutter SB, Collins AB, et al
     A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
     Am J Psychiatry. 2021;178:193-202.
     

     >> Share

     
     January 2021
109. SHMULEWITZ D, Aharonovich E, Witkiewitz K, Anton RF, et al
     The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.
     Am J Psychiatry. 2021 Jan 21:appiajp202020050610.
     

     >> Share

     
     November 2020
110. SINHA R, Wemm S, Fogelman N, Milivojevic V, et al
     Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
     Am J Psychiatry. 2020 Nov 19:appiajp202020050609.
     

     >> Share

     
     October 2020
111. COUGHLIN LN, Pfeiffer P, Ganoczy D, Lin LA, et al
     Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
     Am J Psychiatry. 2020 Oct 29:appiajp202020040454.
     

     >> Share

     
     
112. MATHEW SJ
     Is Testosterone an Effective Hormonal Therapy for Women With Antidepressant-Resistant Major Depression?
     Am J Psychiatry. 2020;177:891-894.
     

     >> Share

     
     
113. KALIN NH
     Insights Into Suicide and Depression.
     Am J Psychiatry. 2020;177:877-880.
     

     >> Share

     
     
114. HOLMANS PA
     Using Genetics to Increase Specificity of Outcome Prediction in Psychiatric Disorders: Prospects for Progression.
     Am J Psychiatry. 2020;177:884-887.
     

     >> Share

     
     
115. FIRTH J, Wootton RE, Carvalho AF
     Toward Preventive Psychiatry: The Role of Advanced Epidemiological Methods.
     Am J Psychiatry. 2020;177:888-890.
     

     >> Share

     
     
116. SUMMERS RF
     The Elephant in the Room: What Burnout Is and What It Is Not.
     Am J Psychiatry. 2020;177:898-899.
     

     >> Share

     
     
117. MEDINA-RODRIGUEZ EM, Madorma D, O'Connor G, Mason BL, et al
     Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice.
     Am J Psychiatry. 2020;177:974-990.
     

     >> Share

     
     
118. DICHTEL LE, Carpenter LL, Nyer M, Mischoulon D, et al
     Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.
     Am J Psychiatry. 2020;177:965-973.
     

     >> Share

     
     August 2020
119. MUELLER SC
     Mental Health Treatment Utilization in Transgender Persons: What We Know and What We Don't Know.
     Am J Psychiatry. 2020;177:657-659.
     

     >> Share

     
     
120. CARPENTER LL, Philip NS
     The Future Is Now? Rapid Advances by Brain Stimulation Innovation.
     Am J Psychiatry. 2020;177:654-656.
     

     >> Share

     
     
121. THASE ME
     Charting Sea Changes in Outpatient Pharmacotherapy of Bipolar Disorder.
     Am J Psychiatry. 2020;177:651-653.
     

     >> Share

     
     
122. DWYER JB, Aftab A, Radhakrishnan R, Widge A, et al
     Hormonal Treatments for Major Depressive Disorder: State of the Art.
     Am J Psychiatry. 2020;177:686-705.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share